{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:43:31Z","timestamp":1789746211751,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,17]]},"DOI":"10.7759\/cureus.26034","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T12:47:20Z","timestamp":1655470040000},"source":"Crossref","is-referenced-by-count":3,"title":["Pembrolizumab-Induced Myocarditis and Pancreatitis in a Patient With Colon Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Victor","family":"Delgado-Lazo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Abdelmottaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Popescu-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood SS","year":"2018","unstructured":"Mahmood SS, Fradley MG, Cohen JV, et al.. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018, 71:1755-64. 10.1016\/j.jacc.2018.02.037","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","author":"Hu JR","year":"2019","unstructured":"Hu JR, Florido R, Lipson EJ, et al.. Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc Res. 2019. 115:854-68. 10.1093\/cvr\/cvz026"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145186","article-title":"Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms","volume":"131","author":"Moslehi J","year":"2021","unstructured":"Moslehi J, Lichtman AH, Sharpe AH, Galluzzi L, Kitsis RN. Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms. J Clin Invest. 2021, 131:10.1172\/JCI145186","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa051","article-title":"Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis","volume":"41","author":"Zhang L","year":"2020","unstructured":"Zhang L, Awadalla M, Mahmood SS, et al.. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J. 2020, 41:1733-43. 10.1093\/eurheartj\/ehaa051","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7366-21","article-title":"Fatal immune checkpoint inhibitor-related pancreatitis","volume":"60","author":"Ueno M","year":"2021","unstructured":"Ueno M, Tsuji Y, Yokoyama T, Koyama T, Uenishi Y, Ishida E, Mizuno M. Fatal immune checkpoint inhibitor-related pancreatitis. Intern Med. 2021, 60:3905-11. 10.2169\/internalmedicine.7366-21","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2019.04.015","article-title":"Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: a systematic review and meta-analysis","volume":"19","author":"George J","year":"2019","unstructured":"George J, Bajaj D, Sankaramangalam K, et al.. Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: a systematic review and meta-analysis. Pancreatology. 2019, 19:587-94. 10.1016\/j.pan.2019.04.015","journal-title":"Pancreatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2021.1899444","article-title":"Acute pancreatitis without abdominal pain induced by administration of nivolumab and ipilimumab","volume":"5","author":"Yamamoto K","year":"2021","unstructured":"Yamamoto K, Oka K, Son R, et al.. Acute pancreatitis without abdominal pain induced by administration of nivolumab and ipilimumab. Mod Rheumatol Case Rep. 2021, 5:425-30. 10.1080\/24725625.2021.1899444","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0502-7","article-title":"Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury","volume":"7","author":"Abu-Sbeih H","year":"2019","unstructured":"Abu-Sbeih H, Tang T, Lu Y, et al.. Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury. J Immunother Cancer. 2019, 7:31. 10.1186\/s40425-019-0502-7","journal-title":"J Immunother Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2020.11.1.3","article-title":"Management of acute pancreatitis associated with checkpoint inhibitors","volume":"11","author":"Rogers BB","year":"2020","unstructured":"Rogers BB, Cuddahy T, Zawislak C. Management of acute pancreatitis associated with checkpoint inhibitors. J Adv Pract Oncol. 2020, 11:49-62. 10.6004\/jadpro.2020.11.1.3","journal-title":"J Adv Pract Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231883","article-title":"Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations","volume":"15","author":"Wolfe D","year":"2020","unstructured":"Wolfe D, Kanji S, Yazdi F, et al.. Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations. PLoS One. 2020, 15:e0231883. 10.1371\/journal.pone.0231883","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243360","article-title":"Simultaneous occurrence of autoimmune pancreatitis and sclerosing cholangitis as immune-related adverse events of pembrolizumab","volume":"14","author":"Suda T","year":"2021","unstructured":"Suda T, Kobayashi M, Kurokawa K, Matsushita E. Simultaneous occurrence of autoimmune pancreatitis and sclerosing cholangitis as immune-related adverse events of pembrolizumab. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-243360","journal-title":"BMJ Case Rep"},{"key":"ref12","article-title":"A case of immune-related adverse events affecting the lungs, skin, and pituitary gland during pembrolizumab treatment (Article in Japanese)","volume":"48","author":"Ito R","year":"2021","unstructured":"Ito R, Tatsuoka H, Hirata T, et al.. A case of immune-related adverse events affecting the lungs, skin, and pituitary gland during pembrolizumab treatment (Article in Japanese). Gan To Kagaku Ryoho. 2021, 48:1265-7.","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100490-pembrolizumab-induced-myocarditis-and-pancreatitis-in-a-patient-with-colon-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:00Z","timestamp":1707507960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100490-pembrolizumab-induced-myocarditis-and-pancreatitis-in-a-patient-with-colon-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.26034","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}